The article "Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A" by J.-X. Ma, Y.-L. Yang, X.-Y. He, X.-M. Pan, Z. Wang, Y.-W. Qian, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4756-4762 DOI: 10.26355/eurrev_201906_18057-PMID: 31210302 has been retracted by in accordance with the Publisher and the Editor in Chief. Following some concerns on PubPeer, the authors were informed of the ongoing investigation and were asked to provide original data and clarify several other issues but remained unresponsive. The journal's investigation confirmed the duplication detected in Figure 3C and D and therefore the manuscript is retracted for Figure duplication. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18057.
{"title":"Retraction Note: Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.","authors":"J-X Ma, Y-L Yang, X-Y He, X-M Pan, Z Wang, Y-W Qian","doi":"10.26355/eurrev_202508_37366","DOIUrl":"https://doi.org/10.26355/eurrev_202508_37366","url":null,"abstract":"<p><p>The article \"Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A\" by J.-X. Ma, Y.-L. Yang, X.-Y. He, X.-M. Pan, Z. Wang, Y.-W. Qian, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4756-4762 DOI: 10.26355/eurrev_201906_18057-PMID: 31210302 has been retracted by in accordance with the Publisher and the Editor in Chief. Following some concerns on PubPeer, the authors were informed of the ongoing investigation and were asked to provide original data and clarify several other issues but remained unresponsive. The journal's investigation confirmed the duplication detected in Figure 3C and D and therefore the manuscript is retracted for Figure duplication. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18057.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 8","pages":"382"},"PeriodicalIF":3.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.26355/eurrev_202508_37360
A Biglia, M C Sacchi, F Maggiore, V Morandi, E Cammarata, M M Ciriello, M R Pellico, L Agatea, C Pelazza, A Roveta, L M Castello
BACKGROUND: Subungual splinter hemorrhages may represent an expression of infective endocarditis as well as autoimmune diseases or neoplasms. Anti-SAE1 autoantibody is directed against a small ubiquitin-like modifier-activating enzyme that plays a role in regulating transcription, cell cycle, and apoptosis. It is specific for dermatomyositis with skin rash and mild muscle involvement, and it can be associated with cancer. CASE REPORT: We describe the case of a patient who developed subungual splinter hemorrhages and acrocyanosis. Infections were excluded, and autoimmunity resulted in anti-SAE1 autoantibodies. A cancer screening found a high-grade urothelial carcinoma. The splinter hemorrhages disappeared after the carcinoma enucleation. CONCLUSIONS: Our case describes an atypical onset of anti-SAE1 dermatomyositis with splinter hemorrhages, potentially linked to urothelial cancer. This highlights the importance of comprehensive cancer screening in patients with unusual dermatomyositis presentations.
{"title":"Case report: atypical anti-SAE1 autoantibody manifestation with splinter hemorrhages as onset, and related to urothelial cancer.","authors":"A Biglia, M C Sacchi, F Maggiore, V Morandi, E Cammarata, M M Ciriello, M R Pellico, L Agatea, C Pelazza, A Roveta, L M Castello","doi":"10.26355/eurrev_202508_37360","DOIUrl":"10.26355/eurrev_202508_37360","url":null,"abstract":"<p><p>BACKGROUND: Subungual splinter hemorrhages may represent an expression of infective endocarditis as well as autoimmune diseases or neoplasms. Anti-SAE1 autoantibody is directed against a small ubiquitin-like modifier-activating enzyme that plays a role in regulating transcription, cell cycle, and apoptosis. It is specific for dermatomyositis with skin rash and mild muscle involvement, and it can be associated with cancer. CASE REPORT: We describe the case of a patient who developed subungual splinter hemorrhages and acrocyanosis. Infections were excluded, and autoimmunity resulted in anti-SAE1 autoantibodies. A cancer screening found a high-grade urothelial carcinoma. The splinter hemorrhages disappeared after the carcinoma enucleation. CONCLUSIONS: Our case describes an atypical onset of anti-SAE1 dermatomyositis with splinter hemorrhages, potentially linked to urothelial cancer. This highlights the importance of comprehensive cancer screening in patients with unusual dermatomyositis presentations.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-rev.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 8","pages":"398-403"},"PeriodicalIF":3.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.26355/eurrev_202508_37364
Z Celik, N K Baygutalp, A F Kilic, S B Tekin, E Bakan, M A Gul, N Yuce
Correction to: Eur Rev Med Pharmacol Sci 2023; 27 (4): 1474-1479-DOI: 10.26355/eurrev_202302_31387-PMID: 36876687 published online on 1 March 2023. This erratum serves to include the ethics approval date and approval number, which were unintentionally omitted from the originally published online version of the article. Therefore, the Ethics Approval statement has been corrected as follows: Institutional ethics approval was obtained from the Clinical Research Ethics Committee of the Faculty of Medicine, Ataturk University on May 30, 2019, with approval number 241, and informed consent was provided by all the participants. There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/31387.
{"title":"Author Correction: Serum irisin levels in colorectal cancer patients.","authors":"Z Celik, N K Baygutalp, A F Kilic, S B Tekin, E Bakan, M A Gul, N Yuce","doi":"10.26355/eurrev_202508_37364","DOIUrl":"https://doi.org/10.26355/eurrev_202508_37364","url":null,"abstract":"<p><p>Correction to: Eur Rev Med Pharmacol Sci 2023; 27 (4): 1474-1479-DOI: 10.26355/eurrev_202302_31387-PMID: 36876687 published online on 1 March 2023. This erratum serves to include the ethics approval date and approval number, which were unintentionally omitted from the originally published online version of the article. Therefore, the Ethics Approval statement has been corrected as follows: Institutional ethics approval was obtained from the Clinical Research Ethics Committee of the Faculty of Medicine, Ataturk University on May 30, 2019, with approval number 241, and informed consent was provided by all the participants. There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/31387.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 8","pages":"381"},"PeriodicalIF":3.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-01DOI: 10.26355/eurrev_202508_37370
P Cavellini, L Andreatta, F Alì, G Bavetta, P Veruggio, A Cesca, D Righi, V Farina, M Berardini, M Iorio, C Zambelli, M Iorio, F Gianfreda, A Palermo, E Minetti
Pub Date : 2025-08-01DOI: 10.26355/eurrev_202508_37358
N A Yetkin, F M Simsek, B Baran, B Rabahoglu, N Tutar, I Gulmez
OBJECTIVE: Parapneumonic effusion (PPE), a pneumonia-related complication, can progress to complicated PPE (CPPE) and often requires invasive treatment. Although early differentiation is essential, the diagnostic role of hematological inflammatory markers remains unclear. This study evaluated hematological inflammatory markers to distinguish between pleural effusion types, particularly CPPE and uncomplicated PPE (uCPPE), in order to identify the most reliable biomarkers. MATERIALS AND METHODS: This retrospective study analyzed 94 cases of pleural effusion classified as transudative, malignant, tuberculous, or PPE. PPE was further divided into CPPE and uCPPE. C-reactive protein (CRP) and procalcitonin (PCT) levels, systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), CRP/albumin-globulin ratio (CAGR), albumin-globulin ratio (AGR), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-lymphocyte ratio (PLR) were analyzed. Receiver Operating Characteristic (ROC) curve analysis was used to determine the diagnostic accuracy via the area under the curve (AUC) and optimal cut-off values. RESULTS: Inflammatory markers effectively differentiated pleural effusion types, with CAGR showing the highest accuracy for PPE diagnosis (AUC, 0.866; cut-off: 13.75; sensitivity = 93.8%, specificity = 51.1%). Among the CPPE and uCPPE markers, MLR demonstrated the best performance (AUC: 0.707; cut-off: 3.615; sensitivity: 87.5%; specificity: 77.8%), followed by NLR (AUC: 0.702) and PLR (AUC: 0.704), whereas SIRI and SII had modest utility. Although MLR showed superior accuracy, the addition of SII improved the sensitivity. CONCLUSIONS: This study demonstrates that among hematological markers, CAGR is the most accurate for diagnosing PPE, while MLR best distinguishes CPPE from uCPPE. However, the limited specificity of CAGR highlights the need for the combined use of biomarkers. Prospective multicenter studies are warranted to validate and refine these findings.
{"title":"Diagnostic value of CRP/Albumin-globulin ratio and monocyte-to-lymphocyte ratio in differentiating parapneumonic effusion types.","authors":"N A Yetkin, F M Simsek, B Baran, B Rabahoglu, N Tutar, I Gulmez","doi":"10.26355/eurrev_202508_37358","DOIUrl":"https://doi.org/10.26355/eurrev_202508_37358","url":null,"abstract":"<p><p>OBJECTIVE: Parapneumonic effusion (PPE), a pneumonia-related complication, can progress to complicated PPE (CPPE) and often requires invasive treatment. Although early differentiation is essential, the diagnostic role of hematological inflammatory markers remains unclear. This study evaluated hematological inflammatory markers to distinguish between pleural effusion types, particularly CPPE and uncomplicated PPE (uCPPE), in order to identify the most reliable biomarkers. MATERIALS AND METHODS: This retrospective study analyzed 94 cases of pleural effusion classified as transudative, malignant, tuberculous, or PPE. PPE was further divided into CPPE and uCPPE. C-reactive protein (CRP) and procalcitonin (PCT) levels, systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), CRP/albumin-globulin ratio (CAGR), albumin-globulin ratio (AGR), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-lymphocyte ratio (PLR) were analyzed. Receiver Operating Characteristic (ROC) curve analysis was used to determine the diagnostic accuracy via the area under the curve (AUC) and optimal cut-off values. RESULTS: Inflammatory markers effectively differentiated pleural effusion types, with CAGR showing the highest accuracy for PPE diagnosis (AUC, 0.866; cut-off: 13.75; sensitivity = 93.8%, specificity = 51.1%). Among the CPPE and uCPPE markers, MLR demonstrated the best performance (AUC: 0.707; cut-off: 3.615; sensitivity: 87.5%; specificity: 77.8%), followed by NLR (AUC: 0.702) and PLR (AUC: 0.704), whereas SIRI and SII had modest utility. Although MLR showed superior accuracy, the addition of SII improved the sensitivity. CONCLUSIONS: This study demonstrates that among hematological markers, CAGR is the most accurate for diagnosing PPE, while MLR best distinguishes CPPE from uCPPE. However, the limited specificity of CAGR highlights the need for the combined use of biomarkers. Prospective multicenter studies are warranted to validate and refine these findings.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-abstract-2-2-scaled.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 8","pages":"387-397"},"PeriodicalIF":3.3,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01DOI: 10.26355/eurrev_202507_37328
A S Karajacob, F Ibrahim, S F Syed Omar, N S Zambry, S T Tay
Bloodstream infections (BSIs) pose a significant health burden in clinical settings, contributing to high morbidity and mortality rates worldwide. This review aims to analyze the trends of bacterial and fungal BSI and blood culture pathogen profiles reported in adolescents and adults in Southeast Asian (SEA) countries, drawing from published studies between 2018 and 2024. A comprehensive literature search was conducted via PubMed, Scopus, Web of Science, and Cochrane Library, analyzing 23 studies that included 14,512 patients from 7 SEA countries. The narrative review highlighted various prevalence rates of bacterial and fungal BSIs among different patient groups: those with indwelling catheters (0.6%-46.9%), sepsis (12.6%-44.5%), and hospitalized patients with other comorbidities (1.1%-29.5%). Blood culture findings revealed that Escherichia coli and Staphylococcus aureus were the most commonly isolated gram-negative and gram-positive bacteria, respectively, while Candida species emerged as the predominant fungal pathogen. Notably, non-albicans Candida species were more common than Candida albicans in SEA fungemia patients. The overall findings of pathogen distribution in blood cultures from SEA patients are consistent with global surveillance data; however, distinct regional pathogens endemic to SEA, particularly Burkholderia pseudomallei and Talaromyces marneffei, were also identified. Significant gaps exist in determining bacterial and fungal BSI epidemiology among vulnerable populations, including the acquisition sources, risk factors, antimicrobial resistance patterns, and mortality rates across the SEA region. Overcoming challenges arising from inadequate surveillance and diagnostic capabilities could significantly reduce the BSI burden in the region.
血液感染(bsi)在临床环境中构成了重大的健康负担,在世界范围内造成了高发病率和高死亡率。本综述旨在分析东南亚(SEA)国家青少年和成人报告的细菌和真菌BSI趋势以及血培养病原体特征,这些趋势来自2018年至2024年发表的研究。通过PubMed、Scopus、Web of Science和Cochrane Library进行了全面的文献检索,分析了23项研究,包括来自7个东南亚国家的14,512名患者。叙述性回顾强调了不同患者组中细菌性和真菌性脑损伤的患病率:留置导管患者(0.6%-46.9%),败血症患者(12.6%-44.5%),住院患者合并其他合并症(1.1%-29.5%)。血培养结果显示,大肠杆菌和金黄色葡萄球菌分别是最常见的革兰氏阴性和革兰氏阳性细菌,而念珠菌是主要的真菌病原体。值得注意的是,在SEA真菌血症患者中,非白色念珠菌比白色念珠菌更常见。SEA患者血培养中病原体分布的总体结果与全球监测数据一致;然而,还发现了东南亚特有的独特区域病原体,特别是假马氏伯克霍尔德菌和马尔尼菲塔拉香菌。在确定脆弱人群中细菌和真菌BSI流行病学方面存在重大差距,包括整个东南亚地区的获取来源、风险因素、抗菌素耐药性模式和死亡率。克服监测和诊断能力不足所带来的挑战可以显著减轻该地区的BSI负担。图形摘要:https://www.europeanreview.org/wp/wp-content/uploads/Graphical-AbstractNEW-BIS.jpg。
{"title":"Trends in bacterial and fungal bloodstream infections in Southeast Asia: A review of blood culture pathogens (2018-2024).","authors":"A S Karajacob, F Ibrahim, S F Syed Omar, N S Zambry, S T Tay","doi":"10.26355/eurrev_202507_37328","DOIUrl":"https://doi.org/10.26355/eurrev_202507_37328","url":null,"abstract":"<p><p>Bloodstream infections (BSIs) pose a significant health burden in clinical settings, contributing to high morbidity and mortality rates worldwide. This review aims to analyze the trends of bacterial and fungal BSI and blood culture pathogen profiles reported in adolescents and adults in Southeast Asian (SEA) countries, drawing from published studies between 2018 and 2024. A comprehensive literature search was conducted via PubMed, Scopus, Web of Science, and Cochrane Library, analyzing 23 studies that included 14,512 patients from 7 SEA countries. The narrative review highlighted various prevalence rates of bacterial and fungal BSIs among different patient groups: those with indwelling catheters (0.6%-46.9%), sepsis (12.6%-44.5%), and hospitalized patients with other comorbidities (1.1%-29.5%). Blood culture findings revealed that Escherichia coli and Staphylococcus aureus were the most commonly isolated gram-negative and gram-positive bacteria, respectively, while Candida species emerged as the predominant fungal pathogen. Notably, non-albicans Candida species were more common than Candida albicans in SEA fungemia patients. The overall findings of pathogen distribution in blood cultures from SEA patients are consistent with global surveillance data; however, distinct regional pathogens endemic to SEA, particularly Burkholderia pseudomallei and Talaromyces marneffei, were also identified. Significant gaps exist in determining bacterial and fungal BSI epidemiology among vulnerable populations, including the acquisition sources, risk factors, antimicrobial resistance patterns, and mortality rates across the SEA region. Overcoming challenges arising from inadequate surveillance and diagnostic capabilities could significantly reduce the BSI burden in the region.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-AbstractNEW-BIS.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 7","pages":"356-374"},"PeriodicalIF":3.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01DOI: 10.26355/eurrev_202507_37329
A Toffalini, N Vigolo, N Rolli, E Paviati, M Gelati, E Danese, G Zoppini
OBJECTIVE: α-tocopherol has a protective role against free radical-induced damage. The intestinal absorption of α-tocopherol is in part carried out by Nieman-Pick1-like1 protein, which is the target of ezetimibe, a drug used for the treatment of hypercholesterolemia. Ezetimibe is frequently prescribed to patients with type 2 diabetes in combination with statins. Therefore, the aim of the present study was to investigate the impact of ezetimibe treatment on the blood level of α-tocopherol. MATERIALS AND METHODS: Two hundred patients affected by type 2 diabetes, regularly attending the diabetes clinic, were recruited. All patients should not have received vitamin supplements in the six months preceding the study. α-tocopherol was measured by reverse-phase high-performance liquid chromatography with UV detection. Other laboratory parameters were determined by standard laboratory procedures. Patients were analyzed according to ezetimibe treatment. A linear multivariate regression analysis was used to estimate the factors associated with α-tocopherol level. RESULTS: The majority of patients were on ezetimibe/statin treatment. Patients taking ezetimibe showed a significantly lower α-tocopherol level, 29.9±5.7 vs. 32.9±7.0 μmol/L (p=0.006) compared to those not taking the drug. Ezetimibe was significantly and negatively associated with α-tocopherol level in the multivariate analysis (β standardized coefficient = -.217, p = .002). CONCLUSIONS: Treatment with ezetimibe can reduce α-tocopherol plasma levels by inhibiting the Niemann-Pick C1-like protein. Future studies are required to address the clinical implications of this finding.
目的:α-生育酚具有抗自由基损伤的保护作用。α-生育酚的肠道吸收部分是由Nieman-Pick1-like1蛋白完成的,该蛋白是用于治疗高胆固醇血症的依zetimibe的靶标。依折替贝常与他汀类药物联合用于2型糖尿病患者。因此,本研究的目的是探讨依折麦比治疗对血液中α-生育酚水平的影响。材料与方法:招募了200名定期到糖尿病诊所就诊的2型糖尿病患者。所有患者在研究前6个月内都不应服用维生素补充剂。α-生育酚采用反相高效液相色谱-紫外检测法测定。其他实验室参数由标准实验室程序确定。根据依折麦布治疗方法对患者进行分析。采用多元线性回归分析α-生育酚水平的相关因素。结果:大多数患者接受依折替贝/他汀类药物治疗。服用依折替米比组α-生育酚水平(29.9±5.7 μmol/L vs. 32.9±7.0 μmol/L)明显低于未服用依折替米比组(p=0.006)。多因素分析显示依折替布与α-生育酚水平呈显著负相关(β标准化系数= -)。217, p = .002)。结论:依折替米贝可通过抑制Niemann-Pick c1样蛋白降低α-生育酚血浆水平。未来的研究需要解决这一发现的临床意义。图形摘要:https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-NEW-2-scaled.jpg。
{"title":"Ezetimibe reduces α-tocopherol levels in type 2 diabetes.","authors":"A Toffalini, N Vigolo, N Rolli, E Paviati, M Gelati, E Danese, G Zoppini","doi":"10.26355/eurrev_202507_37329","DOIUrl":"https://doi.org/10.26355/eurrev_202507_37329","url":null,"abstract":"<p><p>OBJECTIVE: α-tocopherol has a protective role against free radical-induced damage. The intestinal absorption of α-tocopherol is in part carried out by Nieman-Pick1-like1 protein, which is the target of ezetimibe, a drug used for the treatment of hypercholesterolemia. Ezetimibe is frequently prescribed to patients with type 2 diabetes in combination with statins. Therefore, the aim of the present study was to investigate the impact of ezetimibe treatment on the blood level of α-tocopherol. MATERIALS AND METHODS: Two hundred patients affected by type 2 diabetes, regularly attending the diabetes clinic, were recruited. All patients should not have received vitamin supplements in the six months preceding the study. α-tocopherol was measured by reverse-phase high-performance liquid chromatography with UV detection. Other laboratory parameters were determined by standard laboratory procedures. Patients were analyzed according to ezetimibe treatment. A linear multivariate regression analysis was used to estimate the factors associated with α-tocopherol level. RESULTS: The majority of patients were on ezetimibe/statin treatment. Patients taking ezetimibe showed a significantly lower α-tocopherol level, 29.9±5.7 vs. 32.9±7.0 μmol/L (p=0.006) compared to those not taking the drug. Ezetimibe was significantly and negatively associated with α-tocopherol level in the multivariate analysis (β standardized coefficient = -.217, p = .002). CONCLUSIONS: Treatment with ezetimibe can reduce α-tocopherol plasma levels by inhibiting the Niemann-Pick C1-like protein. Future studies are required to address the clinical implications of this finding.</p><p><strong>Graphical abstract: </strong>https://www.europeanreview.org/wp/wp-content/uploads/Graphical-Abstract-NEW-2-scaled.jpg.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 7","pages":"375-380"},"PeriodicalIF":3.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01DOI: 10.26355/eurrev_202507_37327
L Moretti, M Coviello, G Maccagnano, G D Cassano, A Carlet, E Favilla, B Moretti, G Solarino
Objective: The study compared anterior knee laxity and anterior cruciate ligament magnetic resonance signals between healthy and anterior cruciate ligament reconstruction (ACLR) knees after exercise to verify differences. This research can guide future training to reduce the risk of reinjury.
Materials and methods: Fifty-four male footballers between June and August 2022 were enrolled in this case-control study. Subjects who underwent ACLR in the previous 3 years (study group) were compared with healthy volunteers (control group). Each group consisted of twenty-seven patients. Data recorded were anterior tibial translation (ATT) expressed in millimeters using an arthrometer and the ratio of ACL to fat tissue signal intensity using magnetic resonance imaging. Measurements were collected at T0 (at rest), T1 (after 40 minutes of linear running of 3.5 miles), and T2 (after 90 minutes of a regular football match).
Results: No statistical difference was observed in demographic pre-analysis features. No difference was indicated between the two groups according to ATT. Conversely, ACL natives demonstrated significant increases in the ratio of ACL to fat tissue signal intensity when compared with ACLR in the three different measurements. Regarding differences within each group, we demonstrated that anterior knee laxity increased in both groups after 90 minutes of a regular football match. The ACL MRI signal did not differ in the study group, but it increased in the control group after exercise.
Conclusions: Although exhibiting distinct MRI signals, ACL-reconstructed tendons show similar post-exercise joint laxity as healthy ligaments. Looking ahead, leveraging specific insights could help tailor training sessions for preventive purposes.
{"title":"Anterior knee laxity and ACL magnetic resonance signals in healthy and ACL-reconstructed knees following exercise.","authors":"L Moretti, M Coviello, G Maccagnano, G D Cassano, A Carlet, E Favilla, B Moretti, G Solarino","doi":"10.26355/eurrev_202507_37327","DOIUrl":"https://doi.org/10.26355/eurrev_202507_37327","url":null,"abstract":"<p><strong>Objective: </strong>The study compared anterior knee laxity and anterior cruciate ligament magnetic resonance signals between healthy and anterior cruciate ligament reconstruction (ACLR) knees after exercise to verify differences. This research can guide future training to reduce the risk of reinjury.</p><p><strong>Materials and methods: </strong>Fifty-four male footballers between June and August 2022 were enrolled in this case-control study. Subjects who underwent ACLR in the previous 3 years (study group) were compared with healthy volunteers (control group). Each group consisted of twenty-seven patients. Data recorded were anterior tibial translation (ATT) expressed in millimeters using an arthrometer and the ratio of ACL to fat tissue signal intensity using magnetic resonance imaging. Measurements were collected at T0 (at rest), T1 (after 40 minutes of linear running of 3.5 miles), and T2 (after 90 minutes of a regular football match).</p><p><strong>Results: </strong>No statistical difference was observed in demographic pre-analysis features. No difference was indicated between the two groups according to ATT. Conversely, ACL natives demonstrated significant increases in the ratio of ACL to fat tissue signal intensity when compared with ACLR in the three different measurements. Regarding differences within each group, we demonstrated that anterior knee laxity increased in both groups after 90 minutes of a regular football match. The ACL MRI signal did not differ in the study group, but it increased in the control group after exercise.</p><p><strong>Conclusions: </strong>Although exhibiting distinct MRI signals, ACL-reconstructed tendons show similar post-exercise joint laxity as healthy ligaments. Looking ahead, leveraging specific insights could help tailor training sessions for preventive purposes.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 7","pages":"349-355"},"PeriodicalIF":3.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01DOI: 10.26355/eurrev_202507_37337
M Minozzi, S Gerli, G C Di Renzo, E Papaleo, A Ferrari
The article "The efficacy and safety of a single dose of Polyhexamethylene Biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis" by M. Minozzi, S. Gerli, G.C. Di Renzo, E. Papaleo, A. Ferrari, published in Eur Rev Med Pharmacol Sci 2008; 12 (1): 59-65-PMID: 18401974 has been retracted by the Authors in accordance with the Publisher and the Editor in Chief. Following some concerns raised by a third party regarding a possible high degree of textual similarity with a previously published paper, the journal has started an investigation. The authors were informed of the ongoing investigation and were asked to provide original data and clarify several other issues. In response, the authors requested the retraction of the manuscript, citing discrepancies related to the article and expressing a lack of confidence in the accuracy of the information submitted. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/477.
M. Minozzi, S. Gerli, G.C. Di Renzo, E. Papaleo, a . Ferrari发表在2008年《Eur Rev Med Pharmacol Sci》上的文章“细菌性阴道病患者单剂量聚六亚甲基双胍妇科溶液与七剂量阴道格林霉素乳膏的疗效和安全性”;12 (1): 59-65-PMID: 18401974已根据出版商和主编的要求被作者撤回。由于第三方对该论文可能与先前发表的一篇论文高度相似提出了一些担忧,该期刊已开始调查。作者被告知正在进行的调查,并被要求提供原始数据和澄清其他几个问题。作为回应,作者要求撤回稿件,理由是与文章有关的差异,并表示对所提交信息的准确性缺乏信心。这篇文章已被撤回。对于由此造成的任何不便,出版商深表歉意。https://www.europeanreview.org/article/477。
{"title":"Retraction Note: The efficacy and safety of a single dose of Polyhexamethylene Biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis.","authors":"M Minozzi, S Gerli, G C Di Renzo, E Papaleo, A Ferrari","doi":"10.26355/eurrev_202507_37337","DOIUrl":"https://doi.org/10.26355/eurrev_202507_37337","url":null,"abstract":"<p><p>The article \"The efficacy and safety of a single dose of Polyhexamethylene Biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis\" by M. Minozzi, S. Gerli, G.C. Di Renzo, E. Papaleo, A. Ferrari, published in Eur Rev Med Pharmacol Sci 2008; 12 (1): 59-65-PMID: 18401974 has been retracted by the Authors in accordance with the Publisher and the Editor in Chief. Following some concerns raised by a third party regarding a possible high degree of textual similarity with a previously published paper, the journal has started an investigation. The authors were informed of the ongoing investigation and were asked to provide original data and clarify several other issues. In response, the authors requested the retraction of the manuscript, citing discrepancies related to the article and expressing a lack of confidence in the accuracy of the information submitted. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/477.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 7","pages":"347"},"PeriodicalIF":3.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01DOI: 10.26355/eurrev_202507_37339
N Authors Listed
The Editor in Chief and the Publisher are issuing an expression of concern regarding the following article: Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci. 2011 Apr; 15(4): 452-457. PMID: 21608442. This Expression of Concern is issued following a notification from a third party concerning a potential conflict of interest involving Dr. Unfer's role at Loli Pharma, the company marketing inositol-based products. This expression of concern aims to notify a possible bias arising from an undeclared conflict of interest. The authors have been notified of both the ongoing investigation and the publication of this notice. https://www.europeanreview.org/article/929.
{"title":"Expression of Concern.","authors":"N Authors Listed","doi":"10.26355/eurrev_202507_37339","DOIUrl":"10.26355/eurrev_202507_37339","url":null,"abstract":"<p><p>The Editor in Chief and the Publisher are issuing an expression of concern regarding the following article: Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci. 2011 Apr; 15(4): 452-457. PMID: 21608442. This Expression of Concern is issued following a notification from a third party concerning a potential conflict of interest involving Dr. Unfer's role at Loli Pharma, the company marketing inositol-based products. This expression of concern aims to notify a possible bias arising from an undeclared conflict of interest. The authors have been notified of both the ongoing investigation and the publication of this notice. https://www.europeanreview.org/article/929.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 7","pages":"348"},"PeriodicalIF":3.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}